2020
DOI: 10.1016/j.cardfail.2020.09.175
|View full text |Cite
|
Sign up to set email alerts
|

Midodrine As A Bridge To Enable Use of Life Enhancing Therapies In Chronic Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Side effects were seen in less than 5% of patients and were limited to headache, palpitations or jitteriness. The authors concluded that midodrine appears to be feasible and safe and enables GDMT in patients with HFrEF associated with autonomic dysfunction and hypotension [11] . A more challenging situation, even in the hospital setting, arises when a patient with severe congestive heart failure and low blood pressure requires dialysis.…”
Section: Discussionmentioning
confidence: 97%
“…Side effects were seen in less than 5% of patients and were limited to headache, palpitations or jitteriness. The authors concluded that midodrine appears to be feasible and safe and enables GDMT in patients with HFrEF associated with autonomic dysfunction and hypotension [11] . A more challenging situation, even in the hospital setting, arises when a patient with severe congestive heart failure and low blood pressure requires dialysis.…”
Section: Discussionmentioning
confidence: 97%